|
Lawmakers, Watchdogs Turn Up Heat on FDA After Reports of Further Email Monitoring
Lawmakers and watchdog groups are putting a brighter spotlight on the FDA, demanding the agency, HHS and White House take action to ensure whistleblower protections and investigate allegations of inappropriate email monitoring by the drug regulator.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives